Chlamydia pneumoniae infections in patients with community-acquired pneumonia in Slovenia

Scandinavian Journal of Infectious Diseases

Volumn 34, Issue 3, 2002, Pages 172-176

  Keše, Darja ^a   Čižman, Milan ^a   Marin, Jožica ^a   Avšič Zupanc, Tatjana ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ACUTE DISEASE; ADOLESCENT; ADULT; AGE; AGED; ANTIBODY DETECTION; ARTICLE; BACTERIAL PNEUMONIA; BLOOD SAMPLING; CHILD; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; COMMUNICABLE DISEASE; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOFLUORESCENCE TEST; INFANT; MAJOR CLINICAL STUDY; MALE; PATHOGENICITY; POPULATION RESEARCH; PREVALENCE; SLOVENIA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INFANT; MALE; PNEUMONIA, BACTERIAL; PREVALENCE; SEROLOGIC TESTS; SLOVENIA;

EID: 0036216334     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540110077399     Document Type: Article

References (34)

1. C. pneumoniae sp. nov. for Chlamydia sp. strain TWAR
2. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis
3. Serological study of responses to selected pathogens causing respiratory tract infection in the institutionalized elderly
4. Epidemiology of Chlamydia pneumoniae
5. Influence of temperature and relative humidity on the survival of Chlamydia pneumoniae in aerosols
6. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis
7. The etiology of community-acquired pneumoniae among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland
8. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR
9. Chlamydia pneumoniae (TWAR)
10. Multiple pathogens in adult patients admitted with community-acquired pneumonia: A one year prospective study of 346 consecutive patients
11. Prospective study of epidemiology and prognostic factors in community-acquired pneumonia
12. Serology for Chlamydia pneumoniae (TWAR)
13. Standardizing Chlamydia pneumoniae assays: Recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada)
14. Chlamydia pneumoniae serology: Interlaboratory variation in microimmunofluorescence assay results
15. Collaborative multidisciplinary workshop report: Detection, culture, serology, and antimicrobial susceptibility testing of Chlamydia pneumoniae
16. Chlamydia pneumoniae serology: Importance of methodology in patients with coronary heart disease and healthy individuals
17. Chlamydial serology: Comparative diagnostic value of immunoblotting, microimmunofluorescence test, and immunoassays using different recombinant proteins as antigens
18. Incidence of community-acquired pneumonia caused by Chlamydia pneumoniae in Italian patients
19. Acute lower respiratory tract infection associated with Chlamydia pneumoniae in Germany
20. Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection: A prospective multicentre study
21. Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalized patients in Berlin
22. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study
23. Chlamydial antibodies in an elderly Finnish population
24. Serologic evidence for a role for Chlamydia pneumoniae infection in chronic obstructive pulmonary disease
25. Chlamydia pneumoniae is an important cause of community-acquired pneumoniae in school-aged children: Serological results of a prospective, population-based study
26. Prevalence of specific antibodies to Chlamydia pneumoniae in children with acute respiratory infections
27. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: Comparative efficacy and safety of chlarithromycin vs. erythromycin ethylsuccinate
28. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections
29. Antibody response to Chlamydia pneumoniae infection in children with respiratory illness
30. Molecular biology of Chlamydia pneumoniae surface proteins and their role in immunopathogenicity
31. Pneumonia due to Chlamydia pneumoniae: Prevalence, clinical features, diagnosis and treatment
32. Chlamydia pneumoniae community-acquired pneumonia: A review of 62 hospitalized adult patients
33. The epidemic cycle of Chlamydia pneumoniae infection in eastern Finland, 1972-1987
34. Evidence of 2 waves of Chlamydia pneumoniae infection in Gavle, Sweden, 1990-96